Abstract
The specificity of drug targets is a great challenge in the pharma-proteomics field of cancer biology. In particular, bioinformatics methods based on complex networks and Gene Ontologies (GOs) are very useful in this area. This work reviews some bioinformatics concepts and previous studies related to Colorectal Cancer (CRC) research using GOs, complex networks, and related methods. Also, we report new results mapping natural compounds on potential drug target CRC network using GOs. The literature mining along with OMIM database gives the details of diseased genes which are further subjected to design a well connected gene regulatory network for cancer. The resultant network is then extrapolated to proteomics level to sort out the genes only expressed in the specific cancer types. The network is statistically analyzed and represented by the graphical interpretation to encounter the hub nodes and their locally parsed neighbors, ligands multi-receptor docking, and the propensity of drug targets in hub nodes and related sub-networks.
Keywords: Chemo preventive drugs, systems biology, mapping, colon cancer, gene ontology, Open Biomedical Ontologies, Colorectal Cancer, Kyoto Encyclopedia of Genes and Genomes, Unified Medical Language System, National Center for Biomedical Ontology
Current Bioinformatics
Title: Complex Network and Gene Ontology in Pharmacology Approaches:Mapping Natural Compounds on Potential Drug Target Colon Cancer Network
Volume: 6 Issue: 1
Author(s): Biplab Bhattacharjee, R. M. Jayadeepa, Usha Talambedu, Sanghita Banerjee, Jayadev Joshi, Jilu Princy Mole, Joshua Samuel and Sushil Kumar Middha
Affiliation:
Keywords: Chemo preventive drugs, systems biology, mapping, colon cancer, gene ontology, Open Biomedical Ontologies, Colorectal Cancer, Kyoto Encyclopedia of Genes and Genomes, Unified Medical Language System, National Center for Biomedical Ontology
Abstract: The specificity of drug targets is a great challenge in the pharma-proteomics field of cancer biology. In particular, bioinformatics methods based on complex networks and Gene Ontologies (GOs) are very useful in this area. This work reviews some bioinformatics concepts and previous studies related to Colorectal Cancer (CRC) research using GOs, complex networks, and related methods. Also, we report new results mapping natural compounds on potential drug target CRC network using GOs. The literature mining along with OMIM database gives the details of diseased genes which are further subjected to design a well connected gene regulatory network for cancer. The resultant network is then extrapolated to proteomics level to sort out the genes only expressed in the specific cancer types. The network is statistically analyzed and represented by the graphical interpretation to encounter the hub nodes and their locally parsed neighbors, ligands multi-receptor docking, and the propensity of drug targets in hub nodes and related sub-networks.
Export Options
About this article
Cite this article as:
Bhattacharjee Biplab, M. Jayadeepa R., Talambedu Usha, Banerjee Sanghita, Joshi Jayadev, Princy Mole Jilu, Samuel Joshua and Kumar Middha Sushil, Complex Network and Gene Ontology in Pharmacology Approaches:Mapping Natural Compounds on Potential Drug Target Colon Cancer Network, Current Bioinformatics 2011; 6 (1) . https://dx.doi.org/10.2174/157489311795222400
DOI https://dx.doi.org/10.2174/157489311795222400 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Using Nutrigenomics to Evaluate Apoptosis as a Preemptive Target in Cancer Prevention
Current Cancer Drug Targets Vascular Effects of Estrogenic Menopausal Hormone Therapy
Reviews on Recent Clinical Trials Recent Advances in Colon Drug Delivery Technology
Drug Delivery Letters Colon Cancer and Specific Ways to Deliver Drugs to the Large Intestine
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs for Diagnosis and Treatment of Colorectal Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, <i>In silico</i> and <i>In vitro</i> Studies Providing Mechanistic Insight into Their Anticancer Potencies
Medicinal Chemistry Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma
Recent Patents on Anti-Cancer Drug Discovery Targeted – Therapy and Imaging Response: A New Paradigm For Clinical Evaluation?
Reviews on Recent Clinical Trials Erythropoietin and mTOR: A “One-Two Punch” for Aging-Related Disorders Accompanied by Enhanced Life Expectancy
Current Neurovascular Research Current and Future Therapeutic Targets: A Review on Treating Head and Neck Squamous Cell Carcinoma
Current Cancer Drug Targets The Potential Targets and Mechanisms of a Carbazole and Pyrazole Containing Anticancer Compound
Current Cancer Drug Targets 3dswap-pred: Prediction of 3D Domain Swapping from Protein Sequence Using Random Forest Approach
Protein & Peptide Letters Alternative Polyadenylation and Its Impact on Cellular Processes
MicroRNA The Genetic Landscapes of Inflammation-Driven Gastrointestinal Tract Cancers
Current Pharmaceutical Design Marine Derived Anticancer Drugs Targeting Microtubule
Recent Patents on Anti-Cancer Drug Discovery Namitecan: a Hydrophilic Camptothecin with a Promising Preclinical Profile
Current Medicinal Chemistry Optical Image-Guided Cancer Therapy
Current Pharmaceutical Biotechnology The Clinical Perspective on Value of 3D, Thin Slice T2-Weighted Images in 3T Pelvic MRI for Tumors
Current Medical Imaging Induction of Abscopal Anti-Tumor Immunity and Immunogenic Tumor Cell Death by Ionizing Irradiation - Implications for Cancer Therapies
Current Medicinal Chemistry Quinones Derived from Plant Secondary Metabolites as Anti-cancer Agents
Anti-Cancer Agents in Medicinal Chemistry